Influence of carvedilol on anticonvulsant effect of gabapentin

Acta Neurologica Belgica

Volumn 111, Issue 4, 2011, Pages 296-305

  Goel, Radha ^a   Goel, Amit ^b   Kumar, YatendeR ^a  

^a ITS Paramedical College   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Carvedilol; Gabapentin; Increasing current electroshock; Pentylenetetrazole

Indexed keywords

CARCA; CARVEDILOL; GABAPENTIN; GABAPIN; GLUTATHIONE; PENTETRAZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN TISSUE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG POTENTIATION; ELECTRIC SHOCK; LIPID PEROXIDATION; LOCOMOTION; MALE; MEMORY; MOUSE; NONHUMAN; ROTAROD TEST; SEIZURE;

EID: 84855853781     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Abreu RMV, Santos JSLD, Moreno JMA. Effects of carvedilol and its analog BM-910228 on mitochondrial function and oxidative stress. J Pharmacol Exp Ther. 2000;295:1022-1030.
2. Ali A, Ahmad FA, Pillai KK, Vohora D. Evidence of the antiepileptic potential of amiloride with neuro-pharmacological benefits in rodents models of epilepsy and behavior. Epilepsy and behavior. 2004;5:322-328.
3. Ali A, Pillai KK, Pal SN. Effects of folic acid and lamotrigine therapy in some rodent models of epilepsy and behavior. J Pharm Pharmacol. 2003;55:387-391.
4. Ali A, Pillai KK, Pal SN. Some neuropsychopharmacological, biochemical and drug interaction effects of lamotrigine. New Delhi. Jamia Hamdard University. 2001;32-39.
5. Baydas G, Sonkaya E, Tuzcu M, Yasar A, Donder E. Novel role for gabapentin in neuroprotection of central nervous system in streptozotocin-induced diabetic rats. Acta Pharmacologica Sinica. 2005;26: 417-422.
6. Charles FM, Xiao YX, Zhan WP, Ouyang M, Lee A. et al. A distinct role for norepinephrine in memory retrieval. Cell. 2004;117:131-143.
7. Clinckers R, Zgavc T, Vermoesen K, Meurs A, Michotte Y, Smolders I. Pharmacological and neurochemical characterization of the involvement of hippocampal adrenoreceptor subtypes in the modulation of acute limbic seizures. J Neurochem. 2010;115(6):1595-1607.
8. Deckers CL, Czuczwar SJ, Hekster YA, Keyser A, Kubova H. et al. Selection of antiepileptic drug polytherapy based on mechanism of action: The evidence reviewed. Epilpesia. 2000;41:1364-1374.
9. Feuerstein GZ, Ruffolo RR. Carvedilol update IV: Prevention of oxidative stress, cardiac remodeling and progression of congestive heart failure. Drugs Today. 1997;33:453-457.
10. Fink K, Dooley DJ, Meder WP, Suman N, Duffy S. et al. Inhibition of neuronal ca2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology. 2002;42:229-236.
11. Fischer W, Lasek R, Muller M. Anticonvulsant effects of propranolol and their pharmacological modulation. Pol J Pharmacol Pharm. 1985;37:883-896.
12. Fischer W, Muller M. Pharmacological modulation of central monoaminergic systems and influence on the anticonvulsant effectiveness of standard antiepileptics in maximal electroshock seizures. Biomed Biochim Acta. 1988;47:631-645.
13. Fitzgerald PJ. Is elevated norepinephrine an etiological factor in some cases of epilepsy? Seizure. 2010;19(6):311-8.
14. Ghosh MN. Toxicity studies. In: Ghosh MN, editor. Fundamentals of Experimental Toxicology. Calcutta: Scientific Book Agency. 1984;153-158.
15. Goel R, Goel A, Sharma M, Kumar Y. Evidence of the antiepileptic potential of carvedilol with neuro-pharmacological benefits in rodents models of epilepsy and behaviour. Journal of Pharmacy Res. 2010;3:1827-1830.
16. Goel R, Goel A, Maoncha A, Pllai KK. Influence of nebivolol on anticonvulsant effects of lamotrigine. Indian J Pharmacol. 2009;41:41-46.
17. Herrero I, Sanchez-Prieto J. c-AMP-dependent facilitation of glutamate release by β-adrenergic receptors in cerbrocortical nerve terminals. J Biol Chem. 1996; 271:30554-30560.
18. Hesdorffer DC, Hause WA, Annegers JF, Rocca WA. Severe, uncontrolled hypertension and adult-onset Seizures:A case-control study in Rochester. Minnesota, Epilepsia. 1996;37:736-741.
19. Khanna N, Ray A, Alkondon M, Sen P. Effect of β-adrenoceptor antagonists and some related drugs on maximal electroshock seizures in mice. Indian J Exp Biol. 1989;27:128-130.
20. Kitano Y, Usui C, Takasuna K, Hirohashi M, Nomura M. Increasing current electroshock test: A new method for assessment of anti-and pro-convulsant activities of drugs in mice. J Pharmacl Toxicol Methods. 1996;35:25-29.
21. Klotz U, Reimann IW. Pharmacokinetic and pharma-codynamic interaction study of diazepam ad metoprolol. Eur J Clin Pharmacol. 1984;26:223-226.
22. Kunieda T, Zuscik MJ, Boongird A, Perez DM, Lüders HO, Najm IM. Systemic overexpression of the alpha 1B-adrenergic receptor in mice: An animal model of epilepsy. Epilepsia. 2002;43(11):1324-1329.
23. Lesser RP, Luders H, Wyllie E, Dinner DS, Morris HH. Mental deterioration in epilepsy. Epilepsia. 1986; 27:105-123.
24. Loscher W, Honack D, Tylor C. Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci Lett. 1991; 128:150-154.
25. Loscher W, Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 1988;2:145-181.
26. Luchowsk E, Luchowski P, Wielosz M, Kleinrok Z, Czuczwer SJ. et al. Propranolol and metoprolol enhance the anticonvulsant action of valproate and diazepam against maximal electroshock. Pharmacol Biochem behavior. 2002;71:223-31.
27. Lysko PG, Lysko KA, Yue TL, Webb CL, Feuerstein GZ. Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke. 1992;23:1630-1636.
28. Lysko PG, Lysko KA, Webb CL, Feuerstein G. Neuroprotective effects of carvedilol, a new antihypertensive, at the N-methyl-D-aspartate receptor. Neuroscience Letters. 1992;148:34-38.
29. Maneuf YP, Gonzalez MI, Sutton KS, Chung FZ, Pinnock RD. et al. Cellular and molecular action of the putative GABA-mimetic, gabapentin. Cell Mol. Life Sci. 2003;60:742-750.
30. McNamara JO. Cellular and molecular basis of epilepsy. J Neurosci. 1994;14:3413-3425.
31. Nakmura T, Oda Y, Takahashi R, Tanaka K, Hase I, Asada A. Propranolol increases the threshold for lidocaine induced convulsions in awake rats:A direct effect on the brain. Anesth Analg. 2008;106(15): 1450-1455.
32. Nemire RE, Toledo CA, Ramsay RE. A pharmacokinetic study to determine the drug interaction between valproate and propranolol. Pharmacotherapy. 1996;16:1059-1062.
33. Ng GY, Bertrand S, Sullivan R, Ethier N, Wang J. et al. γ-aminobutyric acid type B receptors with specific heterodimer composition and post-synaptic actions in the hippocampal neurons are targets of anticonvulsant gabapentin action. Mol Pharmacol. 2001;59:144-152.
34. Ohkawa H, Ohishi N, Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Biochem.1979;95:351-358.
35. Palomeras E, Sanz P, Cano A, Fossas P. Dystonia in a patient treated with propranolol and gabapentin. Arch Neurol. 2000;57:570-571.
36. Pericic D, Jazvinscak M, Svob D, Mirkovic K. Beta-1 adrenoceptor antagonists potentiate the anticonvulsive effect of swim stress in mice. Pharmacol Biochem Behav. 2000;67:507-510.
37. Pizzanelli C, Lazzeri G, Fulceri F, Giorgi FS, Pasquali L. et al. Lack of α1b-adrenergic receptor protects against epileptic seizures. Epilepsia. 2009;50 (Suppl.1):S59-S64.
38. Prakash AK, Kumar A. Effect of chronic treatment of carvedilol on oxidative stress in an intracerbroventriclar streptozotocin induced model of dementia in rats. J Pharm Pharmacol. 2009;61:1665-1672.
39. Ragozzino ME, Pal SN, Unick K, Steigani MR, Gold PE. Modulation of hippocampal acetylcholine release and spontaneous alternation scores by intra-hippocampal glucose injection. J Neurosci. 1998; 18:1595-1601.
40. Raman IM, Tong G, Jahr CE. β-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase. Neuron. 1996;16:415-421.
41. Reznikoff GA, Manaker S, Rhodes CH, Winokur A, Rainbow TC. Localization and quantification of β-adrenergic receptors in human brain. Neurology. 1986;36:1067-1073.
42. Rutecki PA. Noradrenergic modulation of epileptiform activity in the hioppocampus. Epilepsy Res. 1995; 20:125-136.
43. Sarro GD, Spagnolo C, Gareri P, Gallelli L, Sarro AD. Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice. Eur J Pharmacol. 1998;349:179-185.
44. Savitz SI, Rosenbaum DM, Dinsmore JH. The novel β-blocker, carvedilol, provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metab. 2000;20:1197-1204.
45. Sedlak J, Lindsay RH. Estimation of total protein bound and non-protein bound sulphydryl groups in tissues with ellman's reagent. Anal Biochem. 1968;25: 192-197.
46. Stoop R, Epiney S, Meier E, Pralong E. Modulation of epileptiform discharge in rat limbic system in vitro by noradrenergic agents. Neurosci Lett 2000;287:5-8.
47. Thompson PJ, Trimble MR. Anticonvulsant drugs and cognitive functions. Epilepsia. 1982;23:531-534.
48. Vohora D, Pal SN, Pillai KK. Thioperamide, a selective histamine H3 receptor antagonist, protects against PTZ-induced seizures in mice. Life Sci. 2000;66: 297-301.
49. Watson WP, Robinson E, Little HJ. The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawl syndrome. Neuropharmacology. 1997;36:1369-1375.
50. Yaoita H, Sakabe A, Maehara K, Maruyama Y. Different effects of carvedilol, metoprolol and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. Circulation. 2002;105:975-980.
51. Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R. et al. Carvedilol, a new vasodilator and beta adrenoreceptor antagonist, is a antioxidant and free radical scavenger. J Pharmacol Exp Ther. 1992;263:92-98.
52. Yue TL, Feuerstein GZ. Carvedilol, a new vasodilator and β-adrenoceptor antagonist, inhibits oxygen radicalmediated lipid peroxidation in swine ventricular membranes. Pharmacol Commun. 1992;1:27-35.
53. Zuscik MJ, Sands S, Ross SA, Waugh DJ, Gaivin RJ. Overexpression of the α1b-adrenergic receptor causes apoptotic neurodegeneration: Multiple system atrophy. Nat Med. 2000;6:1388-1394.